1. Cerda B, Llorach R, Ceron JJ, et al. Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur J Nutr. 2003 Jan;42(1):18-28 [First report on absorption of punicalagin].
2. Aviram M, Dornfeld L, Kaplan M, et al. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res. 2002 28(2-3):49-62.
3. Kaplan M, Hayek T, Raz A, et al. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr. 2001 Aug;131(8):2082-9.
4. Huang TH, Peng G, Kota BP, et al. Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids. Br J Pharmacol. 2005 Jul;145(6):767-74.
5. Fuhrman B, Volkova N, Aviram M. Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages. J Nutr Biochem. 2005 Sep;16(9):570-6.
6. Pantuck AJ, Leppert JT, Zomorodian N, et al. Cancer Therapy: Clinical Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer. Clin Cancer Res. 2006 Jul 1;12(13):4018-26.
7. Malik A, Mukhtar H. Prostate cancer prevention through pomegranate fruit. Cell Cycle. 2006 Feb;5(4):371-3.
8. Malik A, Afaq F, Sarfaraz S, et al. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA. 2005 Oct 11;102(41):14813-8.
9. Galli RL, Bielinski DF, Szprengiel A, Shukitt-Hale B, Joseph JA. Blueberry supplemented diet reverses age-related decline in hippocampal HSP70 neuroprotection. Neurobiol Aging. 2006 Feb;27(2):344-50.
10. Joseph JA, Shukitt-Hale B, Denisova NA, et al. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci. 1999 Sep 15;19(18):8114-21.
11. Rimando AM, Nagmani R, Feller DR, et al. Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J Agric Food Chem. 2005 May 4;53(9):3403-7.
12. Rimando AM, Kalt W, Magee JB, et al. Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem. 2004 Jul 28;52(15):4713-9.
13. Lazze MC, Pizzala R, Savio M, et al. Anthocyanins protect against DNA damage induced by tert-butyl-hydroperoxide in rat smooth muscle and hepatoma cells. Mutat Res. 2003 Feb 5;535(1):103-15.
14. Available at: http://www.lef.org/magazine/mag2005/jan2005_cover_green_tea_01.htm. Accessed: September 6, 2006.
15. Fassina G, Vene R, Morini M, et al. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallcatechin-3-gallate. Clin. Cancer Res. 2004 Jul 15;10(14):4865-73.
16. Yang CS, Chung JY Li C, et al. Mechanisms of inhibition of carcinogenesis by tea. Biofactors. 2000 13:(1-4):73-9.
17. Fujiki H. Two stages of cancer prevention with green tea. J Cancer Res Clin Oncol 1999 Nov;125(11):589-97.
18. Xu JZ, Yeung SY, Chang Q, et al. Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers. Br J Nutr. 2004 Jun;91(6):873-81.
19. Miyazawa, T. Absorption, metabolism and antioxidative effects of tea catechins in humans. Biofactors. 2000 13(1-4):55-9.
20. Xie D, Liu G, Zhu G, et al. [-]-Epigallocatechin-3-gallate protects cultured spiral ganglion cells from H202-induced oxidizing damage. Acta Otolaryngol. 2004 May;124(4):464-70.
21. Beliveau, R, Gingras, D. Green tea prevention and treatment of cancer by nutriceuticals. Lancet. 2004 Sep 18;364(9439):1021-2.
22. Kotanidou A. Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of pro-inflammatory molecules in mice. Am J Respir Crit Care Med. 2003 Mar 15;165(6):818-23.
23. Kimata M. Effects of luteolin and other flavonoids on IgE-mediated allergic reactions. Planta Med. 2000 Feb; 66(1):25-9.
24. Surh YJ, Chun KS, Cha HH, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: downregulation of Cox-2 and Inos through suppression of NFkappaB activation. Mut Res. 2001 480;243-268.
25. Zhang Y, Callaway EC. High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. Biochem J. 2002 May 15;364(Pt 1):301-7.
26. Faulkner K, Mithen R, Williamson G. Selective increase of the potential anticarcinogen 4-methylsulphinylbutyl glucosinolate in broccoli. Carcinogenesis. 1998 Apr;19(4):605-9.
27. Vang O, Mortensen J, Andersen O. Biochemical effects of dietary intake of different broccoli samples. II. Multivariate analysis of contributions of specific glucosinolates in modulating cytochrome P-450 and antioxidant defense enzyme activities. Metabolism. 2001 Oct;50(10):1130-5.
28. Smith TK, Mithen R, Johnson IT. Effects of brassica vegetable juice on the induction of apoptosis of aberrant crypt foci in rat colonic mucosal crypts in vivo. Carcinogenesis. 2003 Mar;24(3):491-5.
29. Jackson SJ, Singletary KW. Sulforaphane: a naturally occurring mammary carcinoma mitosis inhibitor, which disrupts tubulin polymerization. Carcinogenesis. 2004 Feb;25(2):219-27.
30. Nestle M. Broccoli sprouts as inducers of carcinogen-detoxifying enzyme systems: clinical, dietary, and policy implications. Proc Natl Acad Sci. 1997;94:11149-51.
31. Talalay P, Fahey JW. Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr. 2001 Nov;131(11 Suppl):3027S-3033S.
32. Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci. 1997 94:10367-72.
33. Hanausek M, Walaszek Z, Slaga TJ. Detoxifying cancer-causing agents to prevent cancer. Integr Cancer Ther. 2003 Jun;2(2):139-44.
34. Walaszek Z, Szemraj J, Narag M, et al. Metabolism, uptake, and excretion of a D-glucaric acid salt and potential use in cancer prevention. Cancer Detect Prev. 1997 21(2):178-90.
35. Walaszek Z, Hanausek M, Sherman U, et al. Antiproliferative effect of dietary glucarate on the Sprague-Dawley rat mammary gland. Cancer Lett. 1990 Jan;49(1):51-7.
36. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994 Nov 9;272(18):1413-20.
37. Wilcox, JK, Catignani, GL, Lazarus, S. Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr. 2003 43(1):1-18.
38. Ahuja KD, Ashton EL, Ball MJ. Effects of lipid-lowering, carotenoid-controlled diets on the oxidative modifications of low-density lipoproteins in free-living humans. Clin Sci. [Lond] 2003 Sep;105(3):355-61.
39. Wertz K, Siler U, Goralczyk R. Lycopene: modes of action to promote prostate health. Arch Biochem Biophys. 2004 Oct 1;430(1):127-34.
40. Visioli F, Galli C. Biological properties of olive oil phytochemicals. Cri Rev Food Sci Nutr. 2002;42(3):209-21.
41. Valavanidis A, Nisiotou C, Papageoriou Y, et al. Comparison of the radical scavenging potential of polar and lipidic fractions of olive oil and other vegetable oils under normal conditions and after thermal treatment. J Agric Food Chem. 2004 Apr 21;52(8):2358-65.
42. Ranalli A, Lucera L, Contento S. Antioxidizing potency of phenol compounds in olive mill wastewater. J Agric Food Chem. 2003 Dec 17;51(26):7636-41.
43. Valavanidis A, Nisiotou C, Papageoriou Y, et al. Comparison of the radical scavenging potential of polar and lipidic fractions of olive oil and other vegetable oils under normal conditions and after thermal treatment. J Agric Food Chem. 2004 Apr 21;52(8):2358-65.
44. Carluccio MA, Siculella L, Ancora MA, et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):622-9.
45. Paiva-Martins F, Gordon MH, Gameiro P. Activity and location of olive oil phenolic antioxidants in liposomes. Chem Phys Lipids. 2003 Jun;124(1):23-36.
46. Haban P, Klvanova J, Zidekova E, et al. Dietary supplementation with olive oil leads to improved lipoprotein spectrum and lower n-6 PUFAs in elderly subjects. Med. Sci. Monit. 2004 Apr;10(4):I49-I54.
47. Vissers MN, Zock PL, Katan MB. Bioavailability and antioxidant effects of olive oil phenols in humans – a review. Eur J Clin Nutr. 2004 Jun;58(6):955-65.
48. Parker RS, Sontag TJ. Cytochrome P-450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem. 2002 Jul 12;277(28):25290-6.
49. Meier R, Tomizaki T, Schulze-Briese C, et al. The molecular basis of vitamin E retention: structure of human alpha-tocopherol transfer protein. J Mol Biol. 2003 Aug 15;331(3):725-34.
50. Ikeda S, Kagaya M, Kobayashi K, et al. Dietary sesame lignans decrease lipid peroxidation in rats fed docosahexaenoic acid. J Nutr Sci Vitaminol [Tokyo]. 2003 Aug;49(4):270-6.
51. Kang MH, Naito M, Sakai K, et al. Mode of action of sesame lignans in protecting low-density lipoprotein against oxidative damage in vitro. Life Sci. 2000;66(2):161-71.
52. Kang MH, Naito M, Tsujihara N, et al. Sesamolin inhibits lipid peroxidation in rat liver and kidney. J Nutr. 1998 Jun;128(6):1018-22.
53. Christen S, Woodall AA, Shigenaga MK, et al. Gamma-tocopherol traps mutagenic electrophiles such as NO(X) complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci. USA 1997 Apr;94(7):3217-22.
54. Grant KE, Chandler RM, Castle AL, et al. Chromium and Exercise Training: Effect on Obese Women. Med Science Sports Exer. 1997 29:992-8.
55. Humphries S, Kushner H, Falkner B. Low dietary magnesium is associated with insulin resistance in a sample of young, non-diabetic Black Americans. Am J Hypertens. 1999 Aug;12(8 Pt 1):747-56.
56. Zhang H, Osada K, Maebashi M, et al. A high biotin diet improves the impaired glucose tolerance of long-term spontaneously hyperglycemic rats with non-insulin-dependent diabetes mellitus. J Nutr Sci Vitaminol (Japan). 1996 Dec;42(6):517-26.
57. Koutsikos D, Fourtounas C, Kapetanaki A, et al. Oral glucose tolerance test after high-dose IV biotin administration in normoglucemic hemodialysis patients. Renal Failure (USA). 1996 Jan;18(1):131-7.
58. Pacheco-Alvarez D, Solorzano-Vargas RS, Del Rio, AL. Biotin in metabolism and its relationship to human disease. Arch Med Res. 2002 Sep-Oct;33(5):439-47.
59. Koike M, Koshizuka K, Yang R, et al.
20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast, and myeloid leukemia cell lines. Anticancer Res. 1999 May-Jun;19(3A):1689-97.
60. Hisatake J, O’Kelly J, Uskokovic MR, et al. Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood. 2001 Apr 15;97(8):2427-33.
61. Dietrich T, Joshipura KJ, Dawson-Hughes B, et al. Association between serum concentrations of 25-hydroxyvitamin D and periodontal disease in the U.S. population. Am J Clin Nutr. 2004 Jul;80(1):108-13.
62. Doetsch AM, Faber J, Lynnerup N, et al. The effect of calcium and vitamin D-3 supplementation on the healing of the proximal humerus fracture: a randomized placebo controlled study. Calcif Tissue Int. 2004 Sep;75(3):183-8.
63. Harwood RH, Sahota O, Gaynor K, et al. A randomized controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham neck of femur study. Age Aging. 2004 Jan;33(1):45-51.